Literature DB >> 25722733

Animal models of regression/progression of kidney disease.

Beom Jin Lim1, Hai-Chun Yang2, Agnes B Fogo2.   

Abstract

Current medical therapies may delay chronic kidney disease progression. However, increasing experimental evidence indicates remission or even regression can be achieved. In order to study mechanisms progression vs. regression by different interventions, appropriate animal models and research design must be implemented. We review key information of selected models, including etiology, pathogenesis, procedure, time course and assessment of potential regression.

Entities:  

Year:  2014        PMID： 25722733      PMCID： PMC4337226          DOI： 10.1016/j.ddmod.2014.06.003

Source DB:  PubMed          Journal:  Drug Discov Today Dis Models        ISSN： 1740-6757


  49 in total

1.  Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1.

Authors:  Li-Jun Ma; Shinya Nakamura; Jean Claude Aldigier; Michele Rossini; Haichun Yang; Xiubin Liang; Ikuko Nakamura; Carmelita Marcantoni; Agnes B Fogo
Journal:  J Am Soc Nephrol       Date:  2005-02-23       Impact factor: 10.121

2.  Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.

Authors:  W A Wilmer; L A Hebert; E J Lewis; R D Rohde; F Whittier; D Cattran; A S Levey; J B Lewis; S Spitalewitz; S Blumenthal; R P Bain
Journal:  Am J Kidney Dis       Date:  1999-08       Impact factor: 8.860

3.  Epithelial phenotypic changes detect cyclosporine in vivo nephrotoxicity at a reversible stage.

Authors:  Pierre Galichon; Nathalie Vittoz; Yi-Chun Xu-Dubois; Emilie Cornaire; Sophie Vandermeersch; Laurent Mesnard; Alexandre Hertig; Eric Rondeau
Journal:  Transplantation       Date:  2011-11-15       Impact factor: 4.939

4.  Glomerular and tubular damage in normotensive and hypertensive rats.

Authors:  Jarle Ofstad; Bjarne M Iversen
Journal:  Am J Physiol Renal Physiol       Date:  2004-11-09

5.  Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: role of sodium intake.

Authors:  L W Elzinga; S Rosen; W M Bennett
Journal:  J Am Soc Nephrol       Date:  1993-08       Impact factor: 10.121

6.  "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.

Authors:  Kimiko Ishiguro; Kaori Hayashi; Hiroyuki Sasamura; Yusuke Sakamaki; Hiroshi Itoh
Journal:  Hypertension       Date:  2008-12-01       Impact factor: 10.190

7.  Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.

Authors:  Marcin Adamczak; Marie-Luise Gross; Jan Krtil; Andreas Koch; Karin Tyralla; Kerstin Amann; Eberhard Ritz
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

8.  Progressive glomerular injury in the MWF rat is predicted by inborn nephron deficit.

Authors:  A Fassi; F Sangalli; R Maffi; F Colombi; E I Mohamed; B M Brenner; G Remuzzi; A Remuzzi
Journal:  J Am Soc Nephrol       Date:  1998-08       Impact factor: 10.121

Review 9.  Animal models of acute renal failure.

Authors:  Amrit Pal Singh; Anselm Junemann; Arunachalam Muthuraman; Amteshwar Singh Jaggi; Nirmal Singh; Kuldeep Grover; Ravi Dhawan
Journal:  Pharmacol Rep       Date:  2012       Impact factor: 3.024

Review 10.  Mouse models of diabetic nephropathy.

Authors:  Frank C Brosius; Charles E Alpers; Erwin P Bottinger; Matthew D Breyer; Thomas M Coffman; Susan B Gurley; Raymond C Harris; Masao Kakoki; Matthias Kretzler; Edward H Leiter; Moshe Levi; Richard A McIndoe; Kumar Sharma; Oliver Smithies; Katalin Susztak; Nobuyuki Takahashi; Takamune Takahashi
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121
View more
  14 in total

1.  ASK1 contributes to fibrosis and dysfunction in models of kidney disease.

Authors:  John T Liles; Britton K Corkey; Gregory T Notte; Grant R Budas; Eric B Lansdon; Ford Hinojosa-Kirschenbaum; Shawn S Badal; Michael Lee; Brian E Schultz; Sarah Wise; Swetha Pendem; Michael Graupe; Laurie Castonguay; Keith A Koch; Melanie H Wong; Giuseppe A Papalia; Dorothy M French; Theodore Sullivan; Erik G Huntzicker; Frank Y Ma; David J Nikolic-Paterson; Tareq Altuhaifi; Haichun Yang; Agnes B Fogo; David G Breckenridge
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

2.  Selonsertib Enhances Kidney Protection Beyond Standard of Care in a Hypertensive, Secondary Glomerulosclerosis CKD Model.

Authors:  Shawn S Badal; Tareq Al Tuhaifi; Ya-Fen Yu; David Lopez; Craig T Plato; Kristin Joly; David G Breckenridge; Hai-Chun Yang; John T Liles; Agnes B Fogo
Journal:  Kidney360       Date:  2022-04-18

3.  Methionine restriction delays aging-related urogenital diseases in male Fischer 344 rats.

Authors:  Despina Komninou; Virginia L Malloy; Jay A Zimmerman; Raghu Sinha; John P Richie
Journal:  Geroscience       Date:  2019-11-14       Impact factor: 7.713

4.  Stabilization of hypoxia-inducible factor ameliorates glomerular injury sensitization after tubulointerstitial injury.

Authors:  Jun Zou; Jaewon Yang; Xiaoye Zhu; Jianyong Zhong; Ahmed Elshaer; Taiji Matsusaka; Ira Pastan; Volker H Haase; Hai-Chun Yang; Agnes B Fogo
Journal:  Kidney Int       Date:  2020-11-01       Impact factor: 10.612

5.  Myocardial Hypertrophy and Fibrosis Are Associated with Cardiomyocyte Beta-Catenin and TRPC6/Calcineurin/NFAT Signaling in Spontaneously Hypertensive Rats with 5/6 Nephrectomy.

Authors:  Evdokia Bogdanova; Olga Beresneva; Olga Galkina; Irina Zubina; Galina Ivanova; Marina Parastaeva; Natalia Semenova; Vladimir Dobronravov
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

6.  Hypercholesterolemia in Progressive Renal Failure Is Associated with Changes in Hepatic Heparan Sulfate - PCSK9 Interaction.

Authors:  Pragyi Shrestha; Saritha Adepu; Romain R Vivès; Rana El Masri; Astrid Klooster; Fleur Kaptein; Wendy Dam; Stephan J L Bakker; Harry van Goor; Bart van de Sluis; Jacob van den Born
Journal:  J Am Soc Nephrol       Date:  2021-03-23       Impact factor: 14.978

7.  Prophylactic orthosteric inhibition of leukocyte integrin CD11b/CD18 prevents long-term fibrotic kidney failure in cynomolgus monkeys.

Authors:  Abbas Dehnadi; A Benedict Cosimi; Rex Neal Smith; Xiangen Li; José L Alonso; Terry K Means; M Amin Arnaout
Journal:  Nat Commun       Date:  2017-01-10       Impact factor: 14.919

8.  Renal chymase-dependent pathway for angiotensin II formation mediated acute kidney injury in a mouse model of aristolochic acid I-induced acute nephropathy.

Authors:  Wen-Yeh Hsieh; Teng-Hsiang Chang; Hui-Fang Chang; Wan-Hsuan Chuang; Li-Che Lu; Chung-Wei Yang; Chih-Sheng Lin; Chia-Chu Chang
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

9.  Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice.

Authors:  Nathalie Le Clef; Anja Verhulst; Patrick C D'Haese; Benjamin A Vervaet
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

10.  Chronic kidney disease with comorbid cardiac dysfunction exacerbates cardiac and renal damage.

Authors:  Shan Liu; Bing H Wang; Darren J Kelly; Henry Krum; Andrew R Kompa
Journal:  J Cell Mol Med       Date:  2017-10-10       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.